XPhyto Therapeutic Corporation (XPHYF) Corporate Media Kit

Diagnostic Pipeline XPhyto Therapeutics Corporation ODF: oral dissolvable film Diagnostics Indication Design and development Feasibility study Final validation CE-Mark Market Rapid RT-PCR COVID-19 Ultra-rapid LFA COVID-19 Peptide biosensor – ODF Infectious disease (multiple) Peptide biosensor – ODF Oral health (multiple) Completed Planned Q3 2021 Q4 2021 Q4 2021 RAPID & Ultra rapid new medical device products Initial launch in Europe USD $39.1 billion The global rapid test market is projected to reach USD $39.1 billion by 2023 with a CAGR of 8.9 % State funding A next generation bioscience company | 9 Q2 2021